also paid a hefty price for an additional 10% of A2/5 when we were hoping for 20% at mates rates.
Rolla
You have shouted this one from the roof top. Daily. It is getting a bit tedious. For what it is worth, the 20% Erin share always had a $ 5 mil price tag attached to it. Owed by Erin to the Government. Clearly referred to by CN when mentioned for the first time and nobody ever mentioned a different number. Previously (before Samo) it was a bargain. Now, what appears to be your opinion, it is a liability. You can pick CN apart, that's fine. But what about this 'little player' from Malaysia? They must be just as blinded.
BTW can anybody imagine the noise if FAR bought all of the 20% for $ 4.5 mil? Or none at all and another player entering the lease? With FAR it seems that they are dammed if they do and dammed if they don't. FAR is not all about CN. There is also the Admiral and other very competent people and nobody likes the current SP.
- Forums
- ASX - By Stock
- FAR
- *FAR Price Target Cut 40% to A$0.06/Share by Morgan Stanley
*FAR Price Target Cut 40% to A$0.06/Share by Morgan Stanley, page-99
-
- There are more pages in this discussion • 178 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FAR (ASX) to my watchlist
|
|||||
Last
51.0¢ |
Change
0.015(3.03%) |
Mkt cap ! $45.74M |
Open | High | Low | Value | Volume |
51.0¢ | 51.0¢ | 51.0¢ | $2.55K | 5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 50223 | 49.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
50.5¢ | 11256 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 50223 | 0.495 |
1 | 30000 | 0.490 |
2 | 32000 | 0.485 |
2 | 28930 | 0.480 |
2 | 70000 | 0.475 |
Price($) | Vol. | No. |
---|---|---|
0.505 | 11256 | 2 |
0.510 | 129688 | 3 |
0.520 | 30000 | 1 |
0.525 | 30000 | 1 |
0.530 | 30000 | 1 |
Last trade - 10.02am 16/07/2024 (20 minute delay) ? |
Featured News
FAR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online